Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000903423-16-001310
Filing Date
2016-10-18
Accepted
2016-10-18 17:23:50
Documents
1
Period of Report
2016-10-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT glaxocrspr3.html 3  
1 OWNERSHIP DOCUMENT glaxocrspr3.xml 3 4553
  Complete submission text file 0000903423-16-001310.txt   6090
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Reporting) CIK: 0001131399 (see all company filings)

State of Incorp.: X0
Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 161941452
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

EIN.: 473173478
SIC: 2836 Biological Products, (No Diagnostic Substances)